临床试验

Cephea Early Feasibility Study

NCT：NCT05061004 · RECRUITING

NCT编号NCT05061004

状态RECRUITING

开始日期2022-04-28

完成时间2031-03-01

SponsorAbbott Medical Devices (INDUSTRY)

First posted2021-09-29

Last updated2026-09-11

简要摘要

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。